Literature DB >> 10947163

Intraabdominal sepsis down-regulates transcription of sodium taurocholate cotransporter and multidrug resistance-associated protein in rats.

P K Kim1, J Chen, K M Andrejko, C S Deutschman.   

Abstract

Hepatic dysfunction in sepsis is characterized by hyperbilirubinemia and intrahepatic cholestasis. We hypothesize that sepsis causes decreased hepatic transcription of the bile acid transporter sodium taurocholate cotransporter (Ntcp) and the organic anion transporter multidrug resistance-associated protein (Mrp2) and that interleukin (IL)-6 is important in the down-regulation of Ntcp and Mrp2 expression. Male Sprague-Dawley rats underwent induction of mild, nonlethal sepsis by cecal ligation and single puncture (CLP) or fulminant sepsis by cecal ligation and double puncture (2CLP). Hepatic transcription of Ntcp and Mrp2 rapidly decreased after CLP or 2CLP. Seventy-two hours later, transcription was 60% of baseline in CLP and 14% of baseline in 2CLP. Serum bilirubin was elevated from 24 h onward and cholestasis was observed on fixed liver specimens at 24, 48, and 72 h after 2CLP but not after CLP. Steady-state Ntcp and Mrp2 mRNA was decreased in IL-6-treated cultured hepatocytes and in normal rats given 1 mg/kg intravenous IL-6. We conclude that 1) Ntcp and Mrp2 transcription is down-regulated transiently after CLP and persistently after 2CLP; 2) 2CLP results in hyperbilirubinemia and cholestasis, in part due to persistently decreased transcription of Ntcp and Mrp2; and 3) altered Ntcp and Mrp2 transcription is mediated in part by IL-6.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10947163     DOI: 10.1097/00024382-200014020-00017

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  17 in total

Review 1.  Liver - guardian, modifier and target of sepsis.

Authors:  Pavel Strnad; Frank Tacke; Alexander Koch; Christian Trautwein
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-12-07       Impact factor: 46.802

Review 2.  Regulation of drug-metabolizing enzymes by local and systemic liver injuries.

Authors:  Yan Guo; Bingfang Hu; Yang Xie; Timothy R Billiar; Jason L Sperry; Min Huang; Wen Xie
Journal:  Expert Opin Drug Metab Toxicol       Date:  2016-01-28       Impact factor: 4.481

Review 3.  Mechanisms of Organ Dysfunction in Sepsis.

Authors:  Rachel Pool; Hernando Gomez; John A Kellum
Journal:  Crit Care Clin       Date:  2017-10-18       Impact factor: 3.598

4.  Use of Organ Dysfunction as a Primary Outcome Variable Following Cecal Ligation and Puncture: Recommendations for Future Studies.

Authors:  Mabel N Abraham; Alexander P Kelly; Ariel B Brandwein; Tiago D Fernandes; Daniel E Leisman; Matthew D Taylor; Mariana R Brewer; Christine A Capone; Clifford S Deutschman
Journal:  Shock       Date:  2020-08       Impact factor: 3.454

Review 5.  The role of inflammation in cholestasis: clinical and basic aspects.

Authors:  Astrid Kosters; Saul J Karpen
Journal:  Semin Liver Dis       Date:  2010-04-26       Impact factor: 6.115

Review 6.  MITOCHONDRIAL FUNCTION IN SEPSIS.

Authors:  Nishkantha Arulkumaran; Clifford S Deutschman; Michael R Pinsky; Brian Zuckerbraun; Paul T Schumacker; Hernando Gomez; Alonso Gomez; Patrick Murray; John A Kellum
Journal:  Shock       Date:  2016-03       Impact factor: 3.454

Review 7.  Regulation of hepatic ABCC transporters by xenobiotics and in disease states.

Authors:  Xinsheng Gu; Jose E Manautou
Journal:  Drug Metab Rev       Date:  2010-08       Impact factor: 4.518

8.  Experimental non-alcoholic fatty liver disease results in decreased hepatic uptake transporter expression and function in rats.

Authors:  Craig D Fisher; Andrew J Lickteig; Lisa M Augustine; Ronald P J Oude Elferink; David G Besselsen; Robert P Erickson; Nathan J Cherrington
Journal:  Eur J Pharmacol       Date:  2009-04-07       Impact factor: 4.432

9.  IL-6 modulates sepsis-induced decreases in transcription of hepatic organic anion and bile acid transporters.

Authors:  Kenneth M Andrejko; Nichelle R Raj; Patrick K Kim; Maurizio Cereda; Clifford S Deutschman
Journal:  Shock       Date:  2008-04       Impact factor: 3.454

10.  Hepatocyte nuclear factor-4alpha is a central transactivator of the mouse Ntcp gene.

Authors:  Andreas Geier; Ina V Martin; Christoph G Dietrich; Natarajan Balasubramaniyan; Sonja Strauch; Frederick J Suchy; Carsten Gartung; Christian Trautwein; Meenakshisundaram Ananthanarayanan
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-05-15       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.